Načítá se...
Emerging data on calcium‐channel blockers: The COHORT study
Multiple studies have demonstrated dihydropyridine calcium‐channel blocker (CCB) therapy to be appropriate for the treatment of hypertension, as is reflected in treatment guidelines such as the Sixth Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High B...
Uloženo v:
| Vydáno v: | Clin Cardiol |
|---|---|
| Hlavní autor: | |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Wiley Periodicals, Inc.
2007
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6654582/ https://ncbi.nlm.nih.gov/pubmed/12622322 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/clc.4960261406 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|